← Leaderboards
Mark A Marzinke
Johns Hopkins University
$21,162,682
Attributed
$34,351,505
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.1M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,351,505 · 4
By mechanism
UM1$26,377,647 · 1
R01$4,075,462 · 2
U19$3,898,396 · 1
Top collaborators
- Susan H Eshleman4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Susan H Eshleman$103,346,426
- Catherine M Gordon$5,650,865
- Stefan David Baral$19,320,514
- Jacques Ravel$18,661,935
- Jennifer Ann Wagman$1,073,998
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsAreaPharmaceutical PreparationsEnsurePre-Exposure ProphylaxisDrug KineticsPharmacologyFumaratesAids PreventionPersonsTenofovirTissuesPlasmaWomanSiteReportingColorectalCommunitiesMedicalEvaluationGenerationsTransgender WomenFormulationBehavioral
Grant awards (16)
LC: HIV PREVENTION TRIALS NETWORK$8,531,038
UM1 · FY2025 · AI
CHIPP-PrEP: Cabotegravir- Hormone Interrogation of Pharmacokinetics-Pharmacodynamics for HIV Prevention$601,598
R01 · FY2025 · AI · contact PI
LC: HIV PREVENTION TRIALS NETWORK$4,024,293
UM1 · FY2024 · AI
CHIPP-PrEP: Cabotegravir-Hormone Interrogation of Pharmacokinetics/Pharmacodynamics for HIV Prevention in Cisgender and Transgender Persons$616,760
R01 · FY2024 · AI · contact PI
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding$567,621
R01 · FY2024 · AI · contact PI
LC: HIV PREVENTION TRIALS NETWORK$6,974,239
UM1 · FY2023 · AI
LC: HIV PREVENTION TRIALS NETWORK$6,848,077
UM1 · FY2022 · AI
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding$567,621
R01 · FY2022 · AI · contact PI
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding$567,621
R01 · FY2021 · AI · contact PI
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding$567,621
R01 · FY2020 · AI · contact PI
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding$586,620
R01 · FY2019 · AI · contact PI
Bioanalytical and Formulation Core$1,155,581
U19 · FY2018 · AI · contact PI
Bioanalytical and Formulation Core$1,147,986
U19 · FY2017 · AI · contact PI
Bioanalytical and Formulation Core$706,733
U19 · FY2016 · AI · contact PI
Bioanalytical and Formulation Core$438,733
U19 · FY2015 · AI · contact PI
Bioanalytical and Formulation Core$449,363
U19 · FY2014 · AI · contact PI